| |JUNE 20269BENGALURU EBOLA SCARE ENDS NEGATIVE, TRIGGERS HEALTH ALERTSTUDY FINDS CAPSAICIN EFFECTIVE FOR DIABETIC NEUROPATHY PAININDIA EMERGES AS R&D HUB AS REGENERON EXPANDS GCCINDIA'S HEATWAVE CRISIS: PREVENT HEATSTROKE BEFORE IT TURNS FATALAs global biopharma companies recalibrate their operating models in an increasingly data-driven R&D setting, the expansion of Global Capability Centers (GCCs) is developing as a fortifying of India's position rather than a cost arbitrage play.Regeneron's decision to establish a second GCC in Hyderabad reflects this structural shift.The Nasdaq-listed biotech firm's upcoming Hyderabad center, its second in India after Bengaluru, is expected to open in the second half of 2026. While on the surface this appears as a routine geographic expansion, the underlying intent strongly signals something more fundamental: the decentralization of high value scientific and operational capabilities. POWith over 10 crore people living with diabetes in India, diabetic neuropathy remains a commonly observed complication, with nearly one in four individuals estimated to experience some form of nerve damage. Painful diabetic India enters into another intense summer cycle; if compared to earlier times, this can be considered the most brutal summer. Now, heatwaves are no longer seasonal disruptions; they are emerging as a public health emergency.Let's look at the numbers with temperatures consistently crossing 45°C across multiple regions. India is witnessing a sharp rise in heat-related illnesses and fatalities.This heatwave crisis is particularly alarming because the official numbers only tell part of the story. While recent reports indicate thousands of heatstroke cases and hundreds of deaths annually, experts suggest that actual mortality could be 10­20 times higher due to underreporting and misclassification of causes. POAsuspected Ebola case in Bengaluru has tested negative, bringing immediate relief to health authorities while simultaneously underscoring the fragile balance between vigilance and panic in a globally connected disease environment.The case involved a 28-year-old woman from Uganda who arrived at Kempegowda International Airport on May 23. She was initially flagged by Airport Health Organization officials for signs of fatigue--an observation that, under normal circumstances, may not trigger alarm. However, given the World Health Organization's (WHO) recent classification of Ebola outbreaks in Uganda and the Democratic Republic of Congo as a Public Health Emergency of International Concern (PHEIC), authorities chose to act with caution. POperipheral neuropathy (DPN), along with postherpetic neuralgia (PHN), causes nerve pain in the hands and feet that feels like tingling, numbness and burning sensations, disrupting sleep, limiting mobility and making everyday activities uncomfortable.To counter this pain, individuals often seek generic muscle pain relief solutions which fail to provide targeted relief against nerve pain. However, solutions containing natural ingredients like Capsaicin (an active compound derived from chili peppers) can help soothe irritated nerves, providing targeted symptomatic relief against nerve pain. POThe divergence is telling: investors are rewarding company-specific execution rather than riding sector-wide sentiment.At a market capitalization of Rs 10,402 crore and trading close to its 52-week high of Rs 6,739, P&G Health is clearly in a phase where performance visibility is translating into valuation confidence. PO
< Page 8 | Page 10 >